Boron-Containing MOF Nanoparticles with Stable Metabolism in U87-MG Cells Combining Microdosimetry To Evaluate Relative Biological Effectiveness of Boron Neutron Capture Therapy

Accurate prediction of the relative biological effectiveness (RBE) of boron neutron capture therapy (BNCT) is challenging. The therapy is different from other radiotherapy; the dynamic distribution of boron-containing compounds in tumor cells affects the therapeutic outcome considerably and hampers...

Full description

Saved in:
Bibliographic Details
Published in:ACS applied materials & interfaces 2024-01, Vol.16 (3), p.3232-3242
Main Authors: Wang, Zhijie, Lei, Runhong, Zhang, Zizhu, Chen, Ziteng, Zhang, Jiaxin, Mao, Meiru, Li, Jiacheng, Tang, Hongyu, Li, Mengyao, Luo, Xianwei, Yang, Jingru, Yan, Ruyu, Liu, Qiuyang, Lv, Linwen, Chen, Kui, Chang, Ya-nan, Yuan, Hui, Liu, Tong, Tong, Jianfei, Zhu, Linbo, Liang, Tianjiao, Zhang, Weihua, Li, Juan, Xing, Gengmei
Format: Article
Language:English
Subjects:
Biological and Medical Applications of Materials and Interfaces
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Accurate prediction of the relative biological effectiveness (RBE) of boron neutron capture therapy (BNCT) is challenging. The therapy is different from other radiotherapy; the dynamic distribution of boron-containing compounds in tumor cells affects the therapeutic outcome considerably and hampers accurate measurement of the neutron-absorbed dose. Herein, we used boron-containing metal–organic framework nanoparticles (BMOFs) with high boron content to target U87-MG cells and maintain the concentration of the 10B isotope in cells. The content of boron in the cells could maintain 90% (60 ppm) within 20 min compared with that at the beginning; therefore, the accurate RBE of BNCT can be acquired. The effects of BNCT upon cells after neutron irradiation were observed, and the neutron-absorbed dose was obtained by Monte Carlo simulations. The RBE of BMOFs was 6.78, which was 4.1-fold higher than that of a small-molecule boron-containing agent (boric acid). The energy spectrum of various particles was analyzed by Monte Carlo simulations, and the RBE was verified theoretically. Our results suggested that the use of nanoparticle-based boron carriers in BNCT may have many advantages and that maintaining a stable boron distribution within cells may significantly improve the efficiency of BNCT.
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.3c19113